Showing results (361-370 of 599) with videos related to
Sort By:
Pageof 60
The Lancet. Haematology|February 22, 2017
Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trialAndrés J M Ferreri, Marianna Sassone, Francesco Zaja, et al.British Journal of Haematology|October 6, 2004
Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'Andrés J M Ferreri, Elías Campo, John F Seymour, et al.Blood|May 24, 2019
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphomaAndrés J M Ferreri, Teresa Calimeri, Gian Marco Conte, et al.Nature Medicine|April 3, 2012
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transferElena Provasi, Pietro Genovese, Angelo Lombardo, et al.Journal of Crohn'S & Colitis|July 18, 2025
Spatiotemporal analysis of Crohn's disease reveals PECAM2 signaling at the basis of inflammation-to-fibrosis transitionLuca Massimino, Tommaso Lorenzo Parigi, Matteo Riva, et al.Blood|November 29, 2002
Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissueEmanuele Zucca, Annarita Conconi, Ennio Pedrinis, et al.The Journal of Pathology|November 29, 2018
Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferationsAliki Xochelli, Vasilis Bikos, Eleftheria Polychronidou, et al.EMBO Molecular Medicine|September 14, 2017
Pathogen-specific B-cell receptors drive chronic lymphocytic leukemia by light-chain-dependent cross-reaction with autoantigensNereida Jiménez de Oya, Marco De Giovanni, Jessica Fioravanti, et al.Nature Reviews. Clinical Oncology|November 2, 2024
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemiaMichele D Stanchina, Skye Montoya, Alexey V Danilov, et al.Blood Cancer Journal|June 28, 2023
Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines AgencyGian Matteo Rigolin, Pier Paolo Olimpieri, Valentina Summa, et al.Pageof 60